Cargando…
Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes
BACKGROUND: Human proteins are widely used as drug targets. Integration of large-scale protein-level genome-wide association studies (GWAS) and disease-related GWAS has thus connected genetic variation to disease mechanisms via protein. Previous proteome-by-phenome-wide Mendelian randomization (MR)...
Autores principales: | Yang, Chengran, Fagan, Anne M., Perrin, Richard J., Rhinn, Herve, Harari, Oscar, Cruchaga, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746220/ https://www.ncbi.nlm.nih.gov/pubmed/36510323 http://dx.doi.org/10.1186/s13073-022-01140-9 |
Ejemplares similares
-
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders
por: Yang, Chengran, et al.
Publicado: (2021) -
Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses
por: Chen, Jie, et al.
Publicado: (2023) -
Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses
por: Yuan, Shuai, et al.
Publicado: (2023) -
Association of HMGCR inhibition with rheumatoid arthritis: a Mendelian randomization and colocalization study
por: Ma, Li, et al.
Publicado: (2023) -
Anti-Epileptic Drug Target Perturbation and Intracranial Aneurysm Risk: Mendelian Randomization and Colocalization Study
por: Bakker, Mark K., et al.
Publicado: (2022)